Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
27 Cards in this Set
- Front
- Back
Zoonotic disease
|
Viral and bacterial diseases transmitted to humans by arthropods,
primarily mosquitoes, ticks, and fleas. |
|
Vector-borne disease
|
Viral and bacterial diseases transmitted to humans by arthropods,
primarily mosquitoes, ticks, and fleas. |
|
Vaccines
|
Biological substances used to stimulate the development of antibodies and
thus confer active immunity against a specific disease or number of diseases. |
|
Vaccine Adverse Event Reporting System (VAERS).
|
A passive surveillance system
that monitors vaccine safety by collecting and analyzing reports of adverse events following immunization from vaccine manufacturers, private practitioners, State and local public health clinics, parents, and individuals who receive vaccines. CDC and the Food and Drug Administration work together to implement VAERS |
|
Surveillance regions:
|
The nine regions of the United States used for influenza surveillance
purposes. |
|
Reportable disease
|
A disease for which there are legal requirements for reporting and
notification to public health authorities. In the United States, requirements for reporting diseases are mandated by State laws or regulations, and the list of reportable diseases in each State differs. |
|
Reemerging infectious diseases
|
Reappearance of a known infection after a decline in
occurrence. Reemergence of “old” infectious agents can be the result of lapses in public health measures, changes in human behavior that increase person-to-person transmission of infectious agents, changes in food handling or eating habits, or changes in the way humans interact with their environment. |
|
Penicillin resistant
|
Having a minimum inhibitory concentration (MIC) equal to or greater
than 2 µg/ml. Strains with “intermediate” susceptibility are not included in this category. |
|
Patient day
|
A day or part of a day for which a patient was hospitalized.
|
|
National Notifiable Disease Surveillance System (NNDSS)
|
Tracking system that State
health departments use to report cases of selected diseases to CDC. (See Reportable disease). |
|
Multiple sex partners
|
More than one partner in the prior 6 months.
|
|
Latent TB infection
|
The state of being infected with the organism Mycobacterium tuberculosis but without signs or symptoms of active TB disease.
|
|
Invasive pneumococcal infection
|
Isolating the bacteria Streptococcus pneumoniae
from a normally sterile site, including blood, cerebrospinal fluid, or pleural fluid. |
|
Hospital-acquired infection
|
Any infection that a patient acquires as a result of medical
treatment while in the hospital. |
|
Group immunity
|
The immunity of a group or community. Immunity based on the resistance
to infection among a high proportion of individual members of the group. |
|
Invasive group B streptococcal disease: Isolation of group B Streptococcus from a
normally sterile site, such as blood or cerebrospinal fluid. |
Isolation of group B Streptococcus from a
normally sterile site, such as blood or cerebrospinal fluid. |
|
Early onset of group B streptococcal diseaseage.
|
Illness onset at less than 7 days of
|
|
Group B Streptococcus (GBS)
|
A normal germ found in the intestines and on the genitals
of about one out of five pregnant women. GBS is usually not harmful to the woman carrying the germ but it can cause dangerous infections in the blood, spinal fluid, and lungs of babies born to these women. |
|
Page 14-52 Healthy People 2010
|
Objectives for Improving Health
population for the first time, the disease has been detected for the first time, or links between an infectious agent and a chronic disease or syndrome have only recently been identified. |
|
Emerging infectious diseases
|
Diseases of infectious origin whose occurrence in humans
has increased within the past two decades or threatens to increase in the near future. Recognition of an emerging disease occurs because the disease is present in the |
|
Distant infection
|
The spread of infection in a patient from one anatomic site to another
site in the body, such as through the blood stream from the lungs to the liver or brain. |
|
Conjugate vaccine
|
A type of inactivated vaccine composed of fractions of bacteria
linked to a protein. This linkage makes the vaccine more potent. |
|
Comprehensive primary care:
|
All aspects of routine health care (preventive, diagnostic,
and therapeutic) delivered by a trained health care provider. |
|
Complete curative therapy:
|
Full course of recommended treatment.
|
|
Common cold:
|
Defined based on International Classification of Disease (ICD)-9
diagnostic codes 460.0, 461.0, 465.0, 465.8, 465.9, and 472.0. |
|
Colonization:
|
The establishment of a colony or growth of an organism in a patient, typically
in a nonsterile anatomic site such as the skin, nasal mucosa, or colon. |
|
Advisory Committee on Immunization Practices (ACIP): Federally chartered advisory
Committee with the goals of providing advice to the CDC Director on decreasing disease Through the use of vaccines and other biological products and on improving the safety of their use. |
Federally chartered advisory
Committee with the goals of providing advice to the CDC Director on decreasing disease Through the use of vaccines and other biological products and on improving the safety of their use. |